Walvax MPV ACYW135

**Walvax MPV ACYW135** is a quadrivalent meningococcal polysaccharide vaccine developed by Yuxi Walvax Biotechnology, a Walvax subsidiary. It contains purified capsular polysaccharide antigens from *Neisseria meningitidis* serogroups A, C, Y, and W135, with 50 micrograms of each serogroup polysaccharide per 0.5 mL dose. The vaccine induces serogroup-specific humoral immune responses that help prevent invasive meningococcal disease caused by these serogroups in people aged 2 years and older. It is supplied as a lyophilized single-dose vaccine that is reconstituted immediately before administration.

Brand names

Walvax MPV ACYW135

Other names

Group ACYW135 Meningococcal Polysaccharide VaccineMeningococcal Polysaccharide Vaccine, Groups A, C, Y and W135 CombinedMPV ACYWMPV ACYW135Quadrivalent meningococcal polysaccharide vaccineYuxi Walvax MPV ACYW